Optimization of Brain Penetrant 11β-Hydroxysteroid Dehydrogenase Type I Inhibitors and in Vivo Testing in Diet-Induced Obese Mice
- 27 January 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 57 (3) , 970-986
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Novel Acidic 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor with Reduced Acyl Glucuronide Liability: The Discovery of 4-[4-(2-Adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic Acid (AZD8329)Journal of Medicinal Chemistry, 2012
- Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistanceProceedings of the National Academy of Sciences, 2011
- Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertensionJournal of the American Society of Hypertension, 2011
- 11β-Hydroxysteroid Dehydrogenase Type 1 Expression Is Increased in the Aged Mouse Hippocampus and Parietal Cortex and Causes Memory ImpairmentsJournal of Neuroscience, 2010
- The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin MonotherapyDiabetes Care, 2010
- A Medicinal Chemist’s Guide to Molecular InteractionsJournal of Medicinal Chemistry, 2010
- Glucocorticoids and Cardiovascular DiseaseEuropean Journal of Endocrinology, 2007
- High-Throughput Screening of Drug−Brain Tissue Binding and in Silico Prediction for Assessment of Central Nervous System Drug DeliveryJournal of Medicinal Chemistry, 2007
- Determination of corticosteroids in tissue samples by liquid chromatography–tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2005
- Structure-based drug design of a new class of antibacterial agentsActa Crystallographica Section A Foundations of Crystallography, 2004